← Eichor
Study identifier: NCT06164795 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Sequential Therapies After Osteoanabolic Treatment

Condition: Osteoporosis, Postmenopausal  ·  Sponsor: 424 General Military Hospital

PhaseN/A
Planned participants150
Who can joinFemale, 50 Years to 85 Years
Healthy volunteersNo

About this study

12-month prospective, open-label, multicenter, international, observational study evaluating sequential treatments after osteoanabolics

This description comes directly from the study's public registry record.

Talk to the study team

Athanasios D Anastasilakis, PhD  ·  2310381431  ·  a.anastasilakis@gmail.com

John Carey, Prof  ·  john.j.carey@universityofgalway.ie

Always discuss trial participation with your own doctor first.

Locations (8)

251 Airforce & VA General HospitalAthens, GreeceRecruiting
First Department of Propaedeutic and Internal Medicine, Medical School, National and Kapodistrian University of AthensAthens, GreeceRecruiting
, KAT General HospitalAthens, GreeceRecruiting
424 General Military HospitalThessaloniki, GreeceRecruiting
Fondazione IRCCS Cà Granda-Ospedale Maggiore PoliclinicoMilan, ItalyRecruiting
Campus Bio-Medico UniversityRoma, ItalyRecruiting
Department of Medicine, Surgery and Neurosciences, University of SienaSiena, ItalyRecruiting
University-Hospital S. Maria della MisericordiaUdine, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06164795